Protokol Lab is a tracker. It helps users record food, weight, doses, symptoms, and notes, and visualizes those records. It does not substitute for professional medical advice, consultation, diagnosis, or treatment. Users assume full and unmitigated responsibility for their individual dosing decisions and schedule adherence.
Protokol Lab does not sell, ship, distribute, refer users to, or endorse any pharmacy, telehealth provider, compounding facility, or substance.
Built-in compound half-lives are provided only for FDA-approved GLP-1 receptor agonists and reflect published peer-reviewed data. Protokol Lab does not publish pharmacokinetic defaults for compounds that are not FDA-approved. Users who choose to track other substances must supply their own half-life values and assume full responsibility for the accuracy of those values and for the legality of any substance they choose to track.
| Compound | Default t½ | Source |
|---|---|---|
| Tirzepatide | ~5 days | Urva S, et al. Clinical Pharmacokinetics (2021) |
| Semaglutide | ~7 days | Lau J, et al. Journal of Medicinal Chemistry (2015) |
| Liraglutide | ~13 hours | Agersø H, et al. Diabetologia (2002) |
| Dulaglutide | ~5 days | Barrington P, et al. Diabetes, Obesity and Metabolism (2011) |
Doses are modeled using the Bateman equation (two-compartment PK with first-order absorption and first-order elimination):
C(t) = D · (ka / (ka − ke)) · (e−ket − e−kat)where D = dose, ka = absorption rate, ke = elimination rate (ln(2) / t½). Stacked doses are summed linearly — a reasonable approximation below receptor saturation.
Pharmacokinetic charts are mathematical estimates for informational purposes only and do not reflect real-time biological or serum diagnostics.
Protokol Lab stores health data in encrypted form on our servers when cloud sync is enabled. Data is never sold, never used for ad targeting, and never shared with third parties. Users can export their complete history as JSON or CSV at any time and delete their account and data permanently from Settings.
Medical questions, source corrections, or research collaborations: [email protected].